News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,231 Results
Type
Article (50675)
Company Profile (379)
Press Release (675177)
Section
Business (212116)
Career Advice (2175)
Deals (36413)
Drug Delivery (102)
Drug Development (84545)
Employer Resources (177)
FDA (16781)
Job Trends (15350)
News (358565)
Policy (33803)
Tag
Academia (2847)
Alliances (52122)
Alzheimer's disease (1316)
Approvals (16701)
Artificial intelligence (157)
Bankruptcy (361)
Best Places to Work (11977)
Biotechnology (270)
Breast cancer (196)
Cancer (1409)
Cardiovascular disease (110)
Career advice (1818)
CAR-T (101)
Cell therapy (305)
Clinical research (67113)
Collaboration (477)
Compensation (248)
COVID-19 (2694)
C-suite (116)
Data (1385)
Diabetes (165)
Diagnostics (6624)
Earnings (86905)
Employer resources (154)
Events (115445)
Executive appointments (377)
FDA (17430)
Funding (433)
Gene therapy (214)
GLP-1 (630)
Government (4538)
Healthcare (19688)
Infectious disease (2786)
Inflammatory bowel disease (118)
Interviews (347)
IPO (16737)
Job creations (3789)
Job search strategy (1552)
Layoffs (443)
Legal (8096)
Lung cancer (206)
Manufacturing (209)
Medical device (13725)
Medtech (13730)
Mergers & acquisitions (19801)
Metabolic disorders (457)
Neuroscience (1650)
NextGen Class of 2024 (6843)
Non-profit (4759)
Northern California (1671)
Obesity (265)
Opinion (198)
Patents (118)
People (58758)
Phase I (21057)
Phase II (29534)
Phase III (21940)
Pipeline (518)
Postmarket research (2666)
Preclinical (9187)
Radiopharmaceuticals (255)
Rare diseases (275)
Real estate (6208)
Regulatory (22619)
Research institute (2544)
Resumes & cover letters (368)
Southern California (1454)
Startups (3822)
United States (15321)
Vaccines (603)
Weight loss (193)
Date
Today (41)
Last 7 days (699)
Last 30 days (2723)
Last 365 days (36811)
2024 (35913)
2023 (41613)
2022 (52857)
2021 (57464)
2020 (56017)
2019 (48651)
2018 (36759)
2017 (33863)
2016 (33481)
2015 (39578)
2014 (33239)
2013 (28821)
2012 (30889)
2011 (31299)
2010 (29312)
Location
Africa (785)
Arizona (206)
Asia (40376)
Australia (6843)
California (3793)
Canada (1421)
China (302)
Colorado (175)
Connecticut (176)
Europe (89109)
Florida (520)
Georgia (140)
Illinois (392)
Indiana (226)
Maryland (638)
Massachusetts (3005)
Michigan (182)
Minnesota (300)
New Jersey (1088)
New York (1068)
North Carolina (817)
Northern California (1671)
Ohio (147)
Pennsylvania (914)
South America (1191)
Southern California (1454)
Texas (553)
Utah (110)
Washington State (412)
726,231 Results for "advanced cell diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology
November 21, 2024
·
4 min read
Biotech Bay
EditCo Bio, Inc. Expands Primary Cell Portfolio with Launch of Knockout CD8+ T-cell Pools
EditCo Bio, Inc., a leader in genome engineering innovation, announced the expansion of its T-cell editing portfolio with the launch of Knockout CD8+ T-cell Pools.
June 27, 2024
·
2 min read
Press Releases
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT’s 2024 Advancing Gene and Cell Therapies for Cancer Conference
PH-894: Potent and Specific Silencing of BRD4 in NK Cells
October 16, 2024
·
4 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Press Releases
European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer
November 27, 2024
·
9 min read
Press Releases
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update
November 25, 2024
·
18 min read
Press Releases
Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite’s Cell Therapy Flagship Program
September 9, 2024
·
5 min read
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Drug Development
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
Tizona Therapeutics, Inc. announced first-in-human Phase 1b clinical data of TTX-080, a novel, first-in-class, antibody targeting HLA-G, in patients with metastatic colorectal cancer and locally advanced/metastatic head and neck squamous cell carcinoma.
May 23, 2024
·
5 min read
Drug Development
New Efficacy Data for Non-Clear Cell Renal Cell Carcinoma From KEYNOTE-B61 Added to LENVIMA® (lenvatinib) US Label Supporting KEYTRUDA + LENVIMA Indication for the First-Line Treatment of Adult Patients With Advanced RCC
Eisai today announced a label update for LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, in the United States to include clinical efficacy data for the first-line treatment of advanced non-clear cell renal cell carcinoma (nccRCC).
June 27, 2024
·
71 min read
1 of 72,624
Next
